← Back to front page
Africa · Regional markets · Moneyweb

Laprophan raises $223m in Africa’s largest Pharma IPO

Published by Moneyweb · South Africa 58 min ago
Laprophan raises $223m in Africa’s largest Pharma IPO
Moneyweb

Detailed summary

The Moroccan firm sold 6.52m existing and new shares at 341 dirhams each, valuing it at about 5.9 billion dirhams.

Laprophan raised 2.22 billion dirhams ($223 million) in an initial public offering on the Casablanca stock exchange, the largest flotation by an African pharmaceutical company.

It was the second-largest IPO by a private Moroccan company, after Societe Generale des Travaux du Maroc last year, Tazi said. Bloomberg-compiled data also show it was the largest pharmaceutical IPO in Africa.

Laprophan, founded in 1949, said it would use the proceeds to acquire a local rival, broaden its product range and expand internationally. Last year, the firm generated 2.5 billion dirhams in revenue and 104 million dirhams in net income.

After a 28% gain in 2025, Morocco’s stock market has given back some of those gains this year, with the benchmark index down about 8% so far in 2026 amid higher input costs tied to Middle East tensions, concerns over credit quality and slower tourism growth.

The World Bank expects the North African economy to grow 4.4% this year, down from 4.9% a year earlier.

Opening of the article, excerpted from Moneyweb. To read the rest, open the article on the publisher's site.

Read the full article on Moneyweb Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.moneyweb.co.za)

Also worth reading